Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and α1-antitrypsin in patients with gastrointestinal malignancies

Clinical Biochemistry

Volumn 37, Issue 1, 2004, Pages 56-60

  Solakidi, Sylvia ^a   Dessypris, Athanassios ^b   Stathopoulos, George P ^b   Androulakis, George ^b   Sekeris, Constantine E ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Biological; C Reactive protein; Carcinoembryonic antigen; Gastrointestinal neoplasms; Kazal pancreatic; Trypsin inhibitor; Tumor markers; 1 Antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; APROTININ; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

EID: 0348111558     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2003.09.002     Document Type: Article

References (16)

1. Stenman U.H., Huhtala M.L., Koistinen R., Seppala M. Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int. J. Cancer. 30:1982;53-57.
2. Fritz H., Huller I., Wiedemann M., Werle E. On protease inhibitors, V. On the chemistry and physiology of the specific trypsin inhibitors from the ox, dog, pig and human pancreas. Hoppe-Seyler. Z. Physiol. Chem. 348:1967;405-418.
3. Huhtala M.L. Demonstration of a new acrosin inhibitor in human seminal plasma. Hoppe-Seyler. Z. Physiol. Chem. 365:1984;819-825.
4. Masuda K., Ogawa M., Murata A., Kitahara T., Kosaki G. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res. Commun. Chem. Pathol. Pharmacol. 40:1983;301-305.
5. Piantino P., Aroasio E. Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases. Scand. J. Clin. Lab. Invest., Suppl. 207:1991;67-69.
6. Taccone W., Mazzon W., Belli M. Evaluation of TATI and other markers in solid tumors. Scand. J. Clin. Lab. Invest., Suppl. 207:1991;25-32.
7. Catarino M., Conde R. Tumor-associated trypsin inhibitor (TATI) in patients with colorectal carcinoma. A critical comparison with CEA. Scand. J. Clin. Lab. Invest., Suppl. 207:1991;43-46.
8. Pasanen P., Eskelinen M., Kulju A., Penttila I., Janatuinen E., Alhava E. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. Scand. J. Clin. Lab. Invest. 55:1995;119-124.
9. Ogawa M. Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin. Biochem. 21:1988;19-25.
10. Ogoshi K., Tajima T., Mitomi T., Tsuda M., Yamamura M. Acute-phase plasma proteins in gastric cancer: association with metastatic potential and prognosis. Tumour Biol. 17:1996;281-289.
11. Stamatiadis A.P., St Toumanidou M., Vyssoulis G.P., Manouras A.J., Apostolidis N.S. Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer. A multivariate analysis. Cancer. 65:1990;2055-2057.
12. McMillan D.C., Wotherspoon H.A., Fearon K.C., Sturgeon C., Cooke T.G., McArdle C.S. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am. J. Surg. 170:1995;319-322.
13. Thompson D., Milford-Ward A., Whicher J.T. The value of acute phase protein measurements in clinical practice. Ann. Clin. Biochem. 29:1992;123-131.
14. Loizate Toricaguena A., Lamiquiz Vallejo A., Dominguez Merru-Urrutia M.J., Legorburu Escudero J.F. Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease. Scand. J. Clin. Lab. Invest., Suppl. 207:1991;59-62.
15. Verspaget H.W. Proteases as prognostic markers in cancer. BMJ. 316:1998;790-791.
16. Stenman U.H., Koivunen E., Itkonen O. Biology and function of tumor-associated trypsin inhibitor TATI. Scand. J. Clin. Lab. Invest., Suppl. 207:1991;5-9.